Specifically, the benzyl alcohol stops bacterial growth inside the vial, which means you can withdraw from a single vial multiple times over several weeks
Seems simple enough, but this process was unique in a few ways

Angiogenic Pathway Activation Multiple components contribute to blood vessel formation through distinct but complementary mechanisms: BPC-157 upregulates VEGFR2 expression and enhances endothelial cell proliferation TB-500 promotes endothelial cell migration and tube formation GHK-Cu stimulates angiogenic growth factor expression and vessel maturation Combined effects result in improved tissue vascularization and nutrient delivery Anti-Inflammatory Pathway Modulation The blend provides comprehensive inflammation control through multiple targets: BPC-157 modulates nitric oxide synthesis and reduces pro-inflammatory cytokines TB-500 influences inflammatory mediator expression through cytoskeletal mechanisms GHK-Cu reduces oxidative stress and modulates immune cell function Coordinated effects help resolve inflammation while promoting healing Synergistic Advantage: GLOW Blends multi-pathway approach enables simultaneous activation of cellular migration, matrix synthesis, angiogenesis, and inflammation control

Brain fog goes to neurology
Social media is buzzing that the FDA approved BPC-157
Best for Best for long-term protocols, value-focused research, or anyone running multi-dose studies needing consistency across higher-volume vials